Inactive Instrument
Norda ASA Share Price Oslo Bors
Stocks
NORD
NO0010285190
Biotechnology & Medical Research
| Market Cap | 51Cr 5.18Cr 4.53Cr 4.19Cr 3.9Cr 7.36Cr 489.83Cr 7.49Cr 50Cr 19Cr 241.71Cr 19Cr 19Cr 842.07Cr | P/E 2023 * |
-
| P/E 2024 | 3.26x |
|---|---|---|---|---|---|
| Enterprise Value | 26Cr 2.67Cr 2.34Cr 2.16Cr 2.01Cr 3.79Cr 252.33Cr 3.86Cr 26Cr 10Cr 124.51Cr 10Cr 9.8Cr 433.78Cr | EV / Sales 2023 |
-1.24x | EV / Sales 2024 | 0.4x |
| Free-Float |
6.26% | Yield 2023 * |
-
| Yield 2024 | 32.5% |
| 09/04 | Exercise of Warrants by primary insiders | AQ |
| 10/25/10 | Mandatory Notification of Trade | AQ |
| 04/25/04 | Ocean Sun: Mandatory notification of trade | AQ |
| 27/25/27 | Nykode Therapeutics - Mandatory Notification of Trade by Closely Associated Party of a Primary Insider | AQ |
| 03/25/03 | Notification of trade | AQ |
| 1 day | +3.37% |
| Manager | Title | Age | Since |
|---|---|---|---|
Frode Westvold
CEO | Chief Executive Officer | - | 08/04/2013 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 54 | 31/01/2014 | |
| Director/Board Member | 68 | 20/06/2013 | |
| Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +3.37% | -6.12% | - | - | 4.47Cr | ||
| +1.15% | +5.94% | -3.40% | +2.32% | 4.66TCr | ||
| -3.03% | +10.57% | +409.46% | +600.67% | 4.1TCr | ||
| -1.42% | +11.82% | +21.53% | -14.79% | 3.23TCr | ||
| -1.89% | +3.08% | +17.59% | +59.64% | 3.22TCr | ||
| -3.29% | +2.85% | +13.80% | +30.30% | 2.55TCr | ||
| +1.86% | +12.60% | - | - | 1.64TCr | ||
| -0.56% | +12.48% | +69.69% | +121.76% | 1.53TCr | ||
| +0.56% | +5.09% | +13.43% | +17.88% | 1.36TCr | ||
| -0.44% | +5.85% | +103.58% | +96.04% | 1.33TCr | ||
| Average | -0.34% | +10.33% | +80.71% | +114.23% | 2.62TCr | |
| Weighted average by Cap. | -0.96% | +10.36% | +94.86% | +137.88% |
| 2023 | 2024 | |
|---|---|---|
| Net sales | 8.69Cr 87.75L 76.81L 70.9L 66.14L 1.25Cr 83Cr 1.27Cr 8.5Cr 3.3Cr 41Cr 3.3Cr 3.22Cr 142.63Cr | 37Cr 3.75Cr 3.29Cr 3.03Cr 2.83Cr 5.33Cr 354.94Cr 5.43Cr 36Cr 14Cr 175.15Cr 14Cr 14Cr 610.18Cr |
| Net income | 3.12Cr 31.47L 27.55L 25.43L 23.72L 44.69L 30Cr 45.49L 3.05Cr 1.18Cr 15Cr 1.18Cr 1.16Cr 51Cr | 13Cr 1.27Cr 1.11Cr 1.03Cr 95.83L 1.81Cr 120.22Cr 1.84Cr 12Cr 4.78Cr 59Cr 4.78Cr 4.67Cr 206.67Cr |
| Net Debt | -31Cr -3.14Cr -2.75Cr -2.54Cr -2.37Cr -4.46Cr -297.09Cr -4.54Cr -30Cr -12Cr -146.6Cr -12Cr -12Cr -510.72Cr | -25Cr -2.51Cr -2.2Cr -2.03Cr -1.89Cr -3.57Cr -237.5Cr -3.63Cr -24Cr -9.45Cr -117.2Cr -9.44Cr -9.23Cr -408.29Cr |
Employees
-
















